Skip to main content

Table 5 Adverse events after treatment with EE/CMA or EE/DRSP

From: A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial

Adverse event

EE /CMA

n (%)

EE /DRSP

n (%)

Breast pain

12 (13.3)

12 (13.3)

Headache

6 (6.7)

9 (10.0)

Nausea

9 (10.0)

8 (8.9)

Dizziness

11 (12.2)

11 (12.2)

Fever

8 (8.9)

3 (3.3)

Flatulence

1 (1.1)

2 (2.2)

Stomachache

2 (2.2)

0 (0.0)

Diarrhea

2 (2.2)

2 (2.2)

Pelvic pain

1 (1.1)

4 (4.4)

Vomiting

2 (2.2)

1 (1.1)

Excessive hungry

4 (4.4)

3 (3.3)

  1. Note: No significant difference between treatment groups